Gene therapies are among the most expensive biopharmaceuticals to develop and manufacture, due in large part to persistent bottlenecks in downstream processing. When purification workflows lose 10% to 30% of vector at each unit operation, it forces developers to make critical tradeoffs to maximize yield without compromising product quality. Join Bioprocess Online on Thursday, May...
Join this thought leadership panel exploring how the CAR-T landscape continues to evolve as clinical and commercial experience grows. As autologous therapies expand into additional settings and allogeneic approaches continue to be studied, organizations are reassessing where to focus research, development, and operational efforts. This discussion brings together perspectives from across the cell therapy ecosystem...
Why Attend The 2026 SNMMI Annual Meeting will feature: Revolutionary research shaping the future of nuclear medicine and molecular imaging Advanced clinical applications transforming patient care Unparalleled networking opportunities with global thought leaders Who Should Attend? The 2026 SNMMI Annual Meeting will feature groundbreaking research and clinical innovation. This critical event unites physicians, technologists, pharmacists,...
Taking a recombinant protein from milligrams to GMP-ready scale is where development programs truly succeed or fail. Join this expert-led webinar to explore the critical decision points that impact scalability, quality, CMC readiness, and time to clinic, with real-world insights you can apply immediately. Key learning objectives: - Navigate expression system selection (microbial, mammalian and...
What You'll Learn: How does life sciences continue to be Boston’s and Cambridge's economic engine amid a softening market? With total VC investment at $6.85B across 197 rounds in 2025, is capital concentrating into fewer winners, and how is that changing tenant decision making? Where are AI enabled life sciences users, automation heavy labs, and data...
At Breakthroughs in Bioprocessing, you'll have the opportunity to: Translate expertise into impact Work alongside Cytiva specialists and industry peers to explore practical, scalable approaches across bioprocess development, manufacturing, and scale-up. Experience innovation beyond theory Engage with advanced technologies in a live, interactive environment designed to support hands-on learning and real-world application. Gain insight through...
Antibody-drug conjugate (ADC) development continues to evolve, with increased molecular complexity leading to new opportunities and challenges across design, development, and manufacturing. The industry is advancing novel technologies to support these next-generation antibody therapies and is adopting workflows better suited to their unique development considerations. In this webinar, we will examine how development teams address...
Join Viralgen, Genosafe and DarkHorse Consulting as they discuss their experience with novel capsid manufacturing, analytical testing and regulatory guidance. Key learning objectives: - Ways to address the complexity of novel capsid manufacturing - Approaches to consider with the analytical testing of novel capsids - Regulatory considerations around novel capsids
This webinar shows how a system-based primary packaging approach—like the West Synchrony™ prefillable syringe system—can streamline tech transfer, simplify GMP qualification, and reduce complexity, cost, and timelines for injectable drug manufacturing. Key Learning Objectives: - How injectable technology transfer impacts project timelines, cost, and risk when working with a CDMO - Where primary packaging decisions...
We are very excited to announce our outdoor Biotech Community Event at SOVA Science District. This is a great opportunity to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. Our last events were a HUGE success with 300 high-quality people registering from over 100+ companies/institutes & we...
